Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Cullinan Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 70 | 71 | +1 |
| Shares | 31.3M | 32.3M | +927.6K (+3.0%) |
| Value | $1.30B | $828.5M | −$470.4M (−36.2%) |
New holders (18)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 1,044,000 | $26.9M | 0.48% |
| Eversept Partners, LP | 163,880 | $4.22M | 0.39% |
| Silverarc Capital Management, LLC | 75,732 | $1.95M | 1.03% |
| Marshall Wace, LLP | 74,951 | $1.93M | 0.01% |
| Affinity Asset Advisors, LLC | 45,000 | $1.16M | 0.55% |
| Boothbay Fund Management, LLC | 39,113 | $1.01M | 0.04% |
| Swiss National Bank | 28,600 | $736.0K | 0.00% |
| Renaissance Technologies LLC | 25,982 | $669.0K | 0.00% |
| State of Wisconsin Investment Board | 15,072 | $388.0K | 0.00% |
| Dark Forest Capital Management LP | 14,172 | $365.0K | 0.16% |
| Alliancebernstein L.P. | 13,800 | $355.0K | 0.00% |
| Credit Suisse AG | 9,031 | $233.0K | 0.00% |
| Virtus ETF Advisers LLC | 7,281 | $187.0K | 0.08% |
| O'Shaughnessy Asset Management, LLC | 2,912 | $75.0K | 0.00% |
| Lazard Asset Management LLC | 2,273 | $58.0K | 0.00% |
| FourThought Financial, LLC | 701 | $18.0K | 0.00% |
| ClariVest Asset Management LLC | 59 | $2.00K | 0.00% |
| Signaturefd, LLC | 29 | $1.00K | 0.00% |
Sold out (17)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Price T Rowe Associates Inc | 723,584 | $30.2M |
| Avidity Partners Management LP | 707,359 | $29.5M |
| Vivo Capital, LLC | 250,000 | $10.4M |
| Janus Henderson Group PLC | 173,471 | $7.23M |
| Wellington Management Group LLP | 154,539 | $6.44M |
| Cormorant Asset Management, LP | 150,000 | $6.25M |
| Farallon Capital Management, L.L.C. | 125,000 | $5.21M |
| Canada Pension Plan Investment Board | 64,000 | $2.67M |
| Caas Capital Management LP | 60,000 | $2.50M |
| Schonfeld Strategic Advisors LLC | 48,373 | $2.02M |
| J. Goldman & Co LP | 42,539 | $1.77M |
| Alyeska Investment Group, L.P. | 25,000 | $1.04M |
| Laurion Capital Management LP | 21,000 | $875.0K |
| TD Asset Management Inc | 18,739 | $781.0K |
| The PNC Financial Services Group, Inc. | 7,356 | $306.0K |
| Voya Investment Management LLC | 5,466 | $228.0K |
| Bank of Montreal | 399 | $14.0K |